![Vann: a virtual community against cancer](https://i0.wp.com/oxsci.org/wp-content/uploads/2024/07/national-cancer-institute-L8tWZT4CcVQ-unsplash-1-scaled.jpg?resize=600%2C400&ssl=1)
Vann: a virtual community against cancer
reports on a new app called Vann which aims to create a community among cancer patients as well as providing treatment tips.
reports on a new app called Vann which aims to create a community among cancer patients as well as providing treatment tips.
Olivia Allen and Enis Gerxhalija discuss cosmic radiation exposure as an occupational risk faced by cabin crew.
Isabel Schmidt discusses why larger animals do not show an increased cancer rate that is expected given their size.
Connor Forsyth discusses the recent explorations into the lung microbiome, and its role in treatment for cancer.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Lola Bell reports on a new study suggesting the size of cancer cells could become a new diagnostic for directing treatment.
Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .
New research has found a novel population of T-cells that may be more successful than current immunotherapy treatments at targeting cancer cells. James O’Brien discusses.
Over the last few decades, our treatment of cancer has been revolutionised. The field has been transformed by a focus on ‘personalised medicine’ which involves treating patients’ individual cases rather than grouping them together. It is universally recognised that there is no single cure for cancer, and increasing evidence suggests that there is not a…